Skip to main content

peginterferon alfa-2a

Generic: peginterferon alfa-2a·Brand: Pegasys

peginterferon alfa-2a: 3 clinical trials tracked.

peginterferon alfa-2a evidence translation

What we can confirm

3 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about peginterferon alfa-2a, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence3 indications · 2 study sponsors
Clinical Trial Registry Records (3)

Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous Angiosarcoma

NCT05799612Registry updated 2026-02-13·Phase 1
Withdrawn

Primary endpoint: Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0

InterventionalRandomizedopen0 targetStarted 2024-03Completion 2024-11M.D. Anderson Cancer Center

A Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of VIR-2218 Alone or in Combination With Pegylated Interferon Alpha-2a

NCT04412863Registry updated 2026-04-16·Phase 2·VIR
Completed

Primary endpoint: Number of Subjects With Adverse Events as Assessed by CTCAE v5.0

Interventionalopen84 enrolledStarted 2020-07Completion 2024-0322 sites · Australia, Hong Kong, Malaysia, New Zealand…Vir Biotechnology, Inc.

A Multicenter, Open-Label Study to Evaluate ARC-520 Administered Alone and in Combination With Other Therapeutics in Patients With Chronic Hepatitis B Virus (HBV) Infection (MONARCH)

NCT02577029Registry updated 2026-01-13·Phase 2·ARWR
Terminated

Primary endpoint: Percentage of Participants Achieving a 1-log Reduction in Hepatitis B Surface Antigen (HBsAg) at Week 60 Compared to Baseline

Interventionalopen79 targetStarted 2015-12Completion 2016-1233 sites · Australia, Bulgaria, China, Moldova…Arrowhead Pharmaceuticals